Will Mirabegron Pass Muster In Overactive Bladder?
This article was originally published in The Pink Sheet Daily
Executive Summary
Astellas aims to muscle in to a growing disease space dominated by muscarinic receptor agonists with its beta-3 agonist mirabegron (YM178) – but first it must get by an FDA advisory committee review.